Siemens Healthineers AG

SHL1

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    74,000

Stocks News & Analysis

stocks

The World Cup stock you’ve never heard of

This ASX stock is kicking goals at the FIFA World Cup.
stocks

Chart of the Week: Can WiseTech shares finally bounce back?

Market concerns over governance and AI fears have left shares trading well below the fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,003.7034.900.39%
CAC 408,338.9712.350.15%
DAX 4025,067.0951.18-0.20%
Dow JONES (US)52,637.01149.600.29%
FTSE 10010,497.2924.840.24%
HKSE24,175.12144.940.60%
NASDAQ26,281.6174.720.29%
Nikkei 22568,557.73813.881.20%
NZX 50 Index13,785.67120.490.88%
S&P 5007,575.3931.750.42%
S&P/ASX 2008,806.0038.200.44%
SSE Composite Index3,996.1640.43-1.00%

Market Movers